Herein, we report central anticholinergic syndrome due to the administration of excessive amounts of cyclopentolate hydrochloride in a child.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Cyclopentolate hydrochloride, belonging to a class of drugs known as anticholinergics, is an ophthalmic solution frequently used in ophthalmology clinics because of its cycloplegic and mydriatic effects in both refractions as well as fundus examinations.
📊
Temel Bulgular & Veri:After application, the maximum cycloplegic effect begins approximately after 30-60 min, which can further continue up to 24 h.
💡
Sonuç & Katkı:Herein, we report central anticholinergic syndrome due to the administration of excessive amounts of cyclopentolate hydrochloride in a child.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Cyclopentolate hydrochloride, belonging to a class of drugs known as anticholinergics, is an ophthalmic solution frequently used in ophthalmology clinics because of its cycloplegic and mydriatic effects in both refractions as well as fundus examinations. After application, the maximum cycloplegic effect begins approximately after 30-60 min, which can further continue up to 24 h. Due to a dose-dependent relationship, cyclopentolate hydrochloride’s side effects can be observed both in an ocular and systemic manner which may occur if solutions more than 0.5% concentration are used. Herein, we report central anticholinergic syndrome due to the administration of excessive amounts of cyclopentolate hydrochloride in a child.
🔖
Bu Makaleye Atıf Yap
KAYMAZ, N., UZUN, M. E., AYLANÇ, H., BATTAL, F., GÜZEL, Y. (2022). Central Anticholinergic Syndrome Following Excessive Mydriatic Use in an Eight-Year-Old Patient. Trends in pediatrics, Cilt: 2 - Sayı: 4, 170–172. https://ajindex.com/articles/598907
Bhatia SS, Vidyashankar C, Sharma RK, Dubey AK. Systemic toxicity with cyclopentolate eye drops. Indian Pediatr. 2000;37:329-31
V Pooniya, N Pandey. Systemic toxicity of topical cyclopentolate eyedrops in a child. Eye (Lond). 2012;26:1391-2
Derinoz O, Er A. Inability to walk, disequilibrium, incoherent speech, disorientation following the instillation of 1% cyclopentolate eyedrops: Case report. Pediatr Emerg Care. 2012;28:59-60
Ağın H, Gerçek H, Kutlu A, Gülez N, Atlıhan F. Topikal siklopentolat kullanımına bağlı gelişen deliryum tablosu: Bir vaka takdimi. Çocuk Sağlığı ve Hastalıkları Derg. 2008;51:39-42
Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol. 1996;80:425-8
Awan KJ. Adverse systemic reactions of topical cyclopentolate hydrochloride. Ann Ophthalmol. 1976;8:695-8
Mirshahi A, Kohnen T. Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature. J Cataract Refract Surg. 2003;29:1026- 30.